PorciSafe MHP Live
Swine Enzootic Pneumonia Vaccine, Live (Strain 168)
Swine Enzootic Pneumonia Vaccine, Live (Strain 168)
The Swine Mycoplasma Hyopneumoniae Vaccine, Live (Strain 168) is designed to prevent swine asthma caused by Mycoplasma hyopneumoniae. This vaccine offers a 6-month immunity period, ensuring effective protection for swine herds. It is specifically formulated for easy administration and minimal adverse reactions.
Key Highlights
- Prevents swine asthma caused by Mycoplasma hyopneumoniae.
- Provides immunity for 6 months.
- Contains 168 strains with ≥10⁶ CCU per dose.
- Quick dissolution for convenient preparation.
- Minimal adverse reactions reported.
Product Characteristics
Five-fold immunisation for complete protection
Space-occupying effect: Strain 168 colonises and protects cilia on alveolar cells, preventing wild-type viruses from attaching and causing pneumonia.
Mucosal immunity: Activates plasma cells in the respiratory mucosa, producing mucosal immunity to block pathogens.
Cellular immunity: Stimulates cytokine release, phagocytosis, and bacterial clearance.
Humoral immunity: Promotes antibody production to form long-term protection.
Replacement of wild virus: Establishes herd immunity, reduces wild virus circulation, and improves survival and productivity.
The vaccine is advanced and widely used
Product Excellence: Developed over 50 years of research; clear strain origin, high antigen content, low immune stress, effective immunisation route.
Significant Innovation: First commercially available Mycoplasma hyopneumoniae vaccine for swine.
Widely Used: Adopted globally in pig farms.
Superior Immunity: Demonstrates better efficacy than inactivated vaccines.
Product Innovation and Internal Control Standards
Technological Innovation: Cell-free culture, low serum culture, advanced fermentation, and purification processes for safety and quality.
Antigen Content: High-dose protection, >10⁶ CCU per dose.
Product Purity: Free of contamination from other pathogens and nucleic acids.
Target Use
- Species:Swine
- Indication:Prevention of swine asthma (Mycoplasma hyopneumoniae)
- Usage Scenario:Suitable for healthy pigs; caution advised on farms with certain infections.
Composition & Presentation
- Antigen:168 strains of Swine Mycoplasma Hyopneumoniae
- Dosage Form:Freeze-dried vaccine
- Vial Volumes:5, 10, 20, 50 doses per bottle
- Route of Administration:Injection into pig lungs
Directions for Use
- Dose:1 dose per pig
- Route:Injection through the 2 cm intercostal space at the posterior edge of the pig’s right scapula
- Reconstitution:Dilute with sterile normal saline as per bottle label
- Use Within:2 hours after dilution
Storage & Stability
- Temperature Range:Store at -15°C
- Shelf Life:18 months unopened
- Post-Reconstitution Stability:Use within 2 hours
Safety & Precautions
- Contraindications:Not for use in pigs with certain infections
- Adverse Reactions:Possible slight fever (<40.5°C) for 1-3 days post-injection
- Handling:Boil remaining solution before disposal
- Drug Interactions:Avoid antibacterial drugs containing mycoplasma 5-15 days before/after immunization
Regulatory & Packaging Information
- Approval Number:SYSZ240051062
- Packaging:5, 10, 20, 50 doses per bottle; 5 or 50 bottles per carton
- Manufacturer:Guizhou Firstv Biological Technology Co. Ltd
FAQ
A: The vaccine provides immunity for 6 months.
A: Store at -15°C with a shelf life of 18 months unopened.